A Member of Genesis Biotechnology Group

Careers Page


Please view our career page for future employment with Venenum Biodesign.

View Job Postings

News and Events


Visit GD3 at booth 1517 at the SOT 63rd Annual Meeting and ToxExpo Mar 10-14 in Salt Lake City, UT #1517

Genesis Drug Discovery & Development (GD3), a member of Genesis Global Group, acquires JSS Medical Research to expand its clinical services portfolio.

Genesis Axis Acquires Organochem to Grow the Preclinical Chemistry Services Portfolio.

Genesis Biotechnology Group Acquires BioBlocks to Grow the Preclinical Chemistry Services Portfolio of Genesis Drug Discovery & Development (GD3)

Genesis Drug Discovery and Development acquires Integrated Analytical Solutions to add “off the shelf” PK profiling capabilities to its portfolio

Genesis Drug Discovery and Development expands its presence in the clinical space by acquiring STATKING Clinical Services

Genesis Biotechnology Group announces second year of CRO relationship with Yale University

Genesis Drug Discovery & Development Appoints Laura Sailor Veteran CRO Business Development Leader as Director of Business Development

Genesis Drug Discovery & Development Appoints Anthony Rohr as Chief Operating Officer

Genesis Biotechnology Group Appoints Erich E. Dagnal as Director of Mergers & Acquisitions

Genesis Biotechnology Group acquires Comparative Biosciences, Inc. (CBI) to add GLP Toxicology and Safety Pharmacology to its portfolio of Preclinical Services

Genesis Drug Discovery & Development (GD3) Announces Appointment of Anthony Rohr, as Chief Executive Officer of PharmOptima

Genesis Biotechnology Group acquires NEDP to grow the Preclinical Chemistry services portfolio of Genesis Drug Discovery & Development (GD3)

Genesis Biotechnology Group® (GBG) Announces First Annual Community Fall Fest in Hamilton

Genesis Drug Discovery & Development Expands Preclinical Contract Research Portfolio by Acquiring NexusPharma

Genesis Drug Discovery & Development Announces Operating Agreement with Ophthy-DS, Inc.

Genesis Biotechnology Group announces partnership with Yale University

Genesis Drug Discovery & Development Appoints Olesia Buiakova, M.D., Ph.D., as Chief Scientific Officer

Abstract accepted for Presentation at The Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting April 29 - May 03, 2018 in Honolulu, Hawaii

Genesis Biotechnology Group Expands Preclinical Contract Research Portfolio by Acquiring PharmOptima

Mercer County Community College has launched a partnership with GBG to give students the opportunity to work while they learn

Biotech Company Sponsors International Bacterial Vaginosis Symposium to Continue Support of Women's Health